Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Press release – No. 15 / 2026 Zealand Pharma to participate in the Morgan Stanley 24 Annual Global Healthcare Conference Copenhagen, Denmark, September 9, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company…
Urogen Pharma: Upside After Bladder Cancer Launch (NASDAQ:URGN)
UroGen Pharma Ltd. has transitioned into a commercial-stage biopharma, driven by strong adoption of Zusduri for recurrent non-muscle-invasive bladder cancer. Zusduri achieved an 80% complete response rate in the ENVISION trial, with a 64.5% chance…
Zealand Pharma: A Play On Medicine Discovery, But Too Expensive Right Now (OTCMKTS:ZLDPF)
Zealand Pharma (ZEAL) offers a differentiated obesity drug pipeline, notably Petrelintide, with strong tolerability and strategic Roche collaboration. ZEAL's Roche deal secures $1.65B upfront plus substantial milestones, 50% profit share in US/EU…
GLP-1 boom pushes pharma companies deeper into wellness, nutraceuticals
The rapid growth of GLP-1 drugs for weight loss is prompting pharmaceutical companies to look beyond the medicines themselves, with wellness and nutraceuticals emerging as adjacent opportunities in the fast-growing weight-management market.
Jim Cramer's top 10 things to watch in the stock market Wednesday
My top 10 things to watch Wednesday, Sept. 9 1. Back to $100 a barrel we go on Brent crude. Stock futures, predictably, are lower this morning. It will be very hard for stocks to rally facing $100 oil this time because of the huge drawdowns of the…
Urogen Pharma (NASDAQ:URGN) Insider Sells $37,383.32 in Stock
Urogen Pharma (NASDAQ:URGN - Get Free Report) insider Mark Schoenberg sold 871 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $42.92, for a total value of $37,383.32. Following the…
BridgeBio Pharma, Inc. $BBIO Shares Bought by Squarepoint Ops LLC
Squarepoint Ops LLC boosted its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 114.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional…
NewAmsterdam Pharma (NASDAQ:NAMS) Shares Down 6.9% - What's Next?
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) was down 6.9% during trading on Wednesday. The company traded as low as $24.25 and last traded at $23.8690. Approximately 167,541 shares traded hands during trading, a decline of 84%…
Urogen Pharma (NASDAQ:URGN) Trading Up 5.9% - Here's What Happened
Shares of Urogen Pharma (NASDAQ:URGN - Get Free Report) traded up 5.9% during mid-day trading on Wednesday. The company traded as high as $46.10 and last traded at $46.39. 65,100 shares changed hands during mid-day trading, a decline of 92% from…
Jason Drew Smith Sells 1,519 Shares of Urogen Pharma (NASDAQ:URGN) Stock
Urogen Pharma (NASDAQ:URGN - Get Free Report) General Counsel Jason Smith sold 1,519 shares of the firm's stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $42.54, for a total value of $64,618.26.
Royalty Pharma PLC $RPRX Shares Sold by C WorldWide Group Holding A S
C WorldWide Group Holding A S lowered its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 28.7% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 471,881…
Wellington Management Group LLP Reduces Stock Position in NewAmsterdam Pharma Company N.V. $NAMS
Wellington Management Group LLP decreased its stake in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 95.7% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional…
Ex-Dem lobbyist for company that promoted addictive opioid clears key gubernatorial hurdle
Cinde Warmington secured the Democratic nomination in New Hampshire's gubernatorial primary on Tuesday evening after running unopposed. Her nomination marks the second time she's pursued the office as Warmington continues to face attacks over her…
C.H. Robinson: The $604 Million Verdict Looks Bigger Than The Economic Risk (NASDAQ:CHRW)
C.H. Robinson Worldwide faces headline risk from a $604 million verdict, but insurance and fault allocation significantly limit direct financial exposure. Montgomery v. Caribe Transport II increases legal risk for brokers, but the true impact will…
2 Dividend Stocks Built to Hold Up When Markets Don't
The S&P 500 has advanced for the past three calendar years and continues to march higher in 2026, even reaching record levels. But this isn't without interruption, particularly in recent months. Investors have worried about the ongoing turmoil in…
Receive a Daily briefing on Pharma Industry News
Get Started